In analogy to what has been discovered in the context of MS and AD, a major question emerges: could NDP52G140E variant play a protective role (through its action on mitochondria and/or pathological Tau) in CD or other diseases associated with inflammation and Tau protein accumulation? This evidence concerns the gene MAPT and Alzheimer disease.